InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,979.96
(
-0.18%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.55
(
0.23%
)
Bitcoin
58,794.82
(
-0.64%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: Gold Seeker post# 10024

Sunday, 10/28/2007 11:06:04 AM

Sunday, October 28, 2007 11:06:04 AM

Post# of 30387
"Cancers of the colon, breast, lung, ovary, stomach, prostate, liver and other cancers that are AFP receptor-positive could potentially be
treated with aimpila."

If Constab's aimpila technology is taken to FDA approval, it shows how important BioCurex's RECAF test will become in the treatment of cancer.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up